Tempest Therapeutics, Inc.
TPST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $39 | $31 | $52 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $15 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $31 | $40 | $33 | $69 |
| Property Plant & Equip (Net) | $10 | $11 | $13 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $10 | $11 | $13 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41 | $52 | $46 | $73 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $1 |
| Short-Term Debt | $7 | $5 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $5 | $18 |
| Total Curr. Liab. | $14 | $9 | $7 | $20 |
| LT Debt | $8 | $15 | $21 | $17 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $15 | $21 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $10 | $12 | $3 |
| Total Liabilities | $22 | $25 | $28 | $37 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$207 | -$165 | -$136 | -$100 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $226 | $192 | $154 | $136 |
| Total Equity | $19 | $27 | $18 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41 | $52 | $46 | $73 |
| Net Debt | -$15 | -$19 | -$9 | -$33 |